EG 427 PINPOINT GENE THERAPY
Live / Registered — Registered (as of 27 Dec 2022)
What this means for you
Registered since 27 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90792354
- Registration number
- 6933394
- Mark type
- Design + words
- Filed
- 24 Jun 2021
- Published for opposition
- 11 Oct 2022
- Registered
- 27 Dec 2022
- Attorney of record
- Pina Campagna
Goods and services
- Class 001 — Chemicals: Chemical and biochemical preparations for scientific and research purposes; reagents for scientific and research purposes; chemical preparations and chemical reagents for industrial, agri-food, cosmetic, pharmaceutical and environmental purposes, other than for medical or veterinary use; Stem cells for research purposes; Bacterial, bacteriological, biological and chemical preparations for scientific purposes other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use as treatments of neurological pathologies; biological tissue cultures for medical purposes; albuminous preparations for medical purposes; chemical preparations for use as treatments of neurological pathologies; Chemical and biological reagents for medical, pharmaceutical or veterinary purposes; reagents and culture media for in vitro medical, pharmaceutical or veterinary diagnosis; Pharmaceutical preparations for human use for the treatment of neurological pathologies; Bacterial, bacteriological, biological and chemical preparations for medical and therapeutic purposes, namely, for treatment of neurological pathologies
- Class 010 — Medical apparatus: Surgical apparatus and instruments for medical or veterinary use; therapeutic and assistive devices to diagnose or administer treatments for cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, sight, hearing, pulmonary and skin diseases, designed for people with disabilities; In vitro diagnostic apparatus and instruments for medical, pharmaceutical or veterinary use in the field of gene therapy for diagnosis of cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, and skin diseases
Owner
Prosecution history
- 27 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Oct 2022 — PUBLISHED FOR OPPOSITION
- 21 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Sept 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 02 Sept 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 26 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Aug 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Mar 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Mar 2022 — NON-FINAL ACTION E-MAILED
- 25 Mar 2022 — NON-FINAL ACTION WRITTEN
- 16 Mar 2022 — ASSIGNED TO EXAMINER